Literature DB >> 23839244

Late relapse of testis cancer.

Yaron Ehrlich1, Eli Rosenbaum, Jack Baniel.   

Abstract

Most relapses of germ-cell tumors occur within 2 years of initial treatment. In 2 % to 4 % of patients, relapse may occur later. The retroperitoneum is the primary site of late relapses, and alpha-fetoprotein is the predominant marker. These tumors are highly resistant to chemotherapy. Surgical resection is the preferred treatment. If the recurrent disease is inoperable, salvage chemotherapy may be instituted, followed by resection of the residual disease.

Entities:  

Mesh:

Year:  2013        PMID: 23839244     DOI: 10.1007/s11934-013-0355-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  60 in total

1.  Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

Authors:  K Fizazi; S Tjulandin; R Salvioni; J R Germà-Lluch; J Bouzy; D Ragan; C Bokemeyer; A Gerl; A Fléchon; J S de Bono; S Stenning; A Horwich; J Pont; P Albers; U De Giorgi; M Bower; A Bulanov; G Pizzocaro; J Aparicio; C R Nichols; C Théodore; J T Hartmann; H J Schmoll; S B Kaye; S Culine; J P Droz; C Mahé
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

2.  Germ cell tumour: late recurrence after 43 years.

Authors:  S Mukhtar; J Beatty; S Agrawal; T J Christmas; C Jameson; R A Huddart
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

3.  Clinical study of six cases showing late relapse of germ cell tumors.

Authors:  Mototsugu Muramaki; Isao Hara; Hideaki Miyake; Yuji Yamada; Gaku Kawabata; Sadao Kamidono
Journal:  Int J Urol       Date:  2005-09       Impact factor: 3.369

Review 4.  Late relapses of germ cell malignancies: incidence, management, and prognosis.

Authors:  Jan Oldenburg; Jarad M Martin; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

5.  Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Authors:  R T D Oliver; M D Mason; G M Mead; H von der Maase; G J S Rustin; J K Joffe; R de Wit; N Aass; J D Graham; R Coleman; S J Kirk; S P Stenning
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

6.  Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis.

Authors:  Jun Sugimura; Richard S Foster; Oscar W Cummings; Eric J Kort; Masayuki Takahashi; Todd T Lavery; Kyle A Furge; Lawrence H Einhorn; Bin Tean Teh
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

7.  Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.

Authors:  L H Einhorn
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

Review 8.  Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.

Authors:  H Schefer; S Mattmann; R A Joss
Journal:  Ann Oncol       Date:  1998-06       Impact factor: 32.976

9.  Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer.

Authors:  M B Garnick
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

10.  Pulsatile secretion of human chorionic gonadotropin in normal adults.

Authors:  W D Odell; J Griffin
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

View more
  3 in total

1.  28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically.

Authors:  James R Hayes; Michael A S Jewett; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2016-07-12       Impact factor: 1.862

2.  Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy.

Authors:  Klaus-Peter Dieckmann; Petra Anheuser; Ralf Gehrckens; Waldemar Wilczak; Guido Sauter; Doris Höflmayer
Journal:  Case Rep Oncol Med       Date:  2017-03-07

3.  Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.

Authors:  Isabel Blancas; Nuria Cárdenas; Mayte Delgado; Jose Miguel Jurado; Marta Legeren; Ana Villaescusa; Fernando Galvez; Marisol Yelamos
Journal:  Oncol Lett       Date:  2014-09-10       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.